Completed Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty NCT00667446 Conditions Central Precocious Puberty (CPP), Depot Formulation, Endocrine System Diseases, +12 more Locations Site Reference ID/Investigator# 13521 — Birmingham, Alabama, United States Site Reference ID/Investigator# 14922 — Long Beach, California, United States Site Reference ID/Investigator# 26043 — Los Angeles, California, United States Site Reference ID/Investigator# 20802 — San Diego, California, United States View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
